Hypothalamic leptin regulation of energy homeostasis and glucose metabolism

Journal of Physiology

Volumn 583, Issue 2, 2007, Pages 437-443

  Morton, Gregory J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; LEPTIN RECEPTOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3 KINASE; PROOPIOMELANOCORTIN; MELANOCORTIN RECEPTOR; STAT3 PROTEIN;

CONFERENCE PAPER; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY; WEIGHT GAIN; ARTICLE; BINDING AFFINITY; BRAIN REGION; GENE TARGETING; GENE THERAPY; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; INSULIN RESPONSE; INSULIN SENSITIVITY; NERVE CELL; NONVIRAL GENE THERAPY; NUTRIENT AVAILABILITY; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THALAMUS VENTRAL NUCLEUS;

ANIMALS; DIABETES MELLITUS, TYPE 2; EATING; ENERGY METABOLISM; FEEDBACK, BIOCHEMICAL; GLUCOSE; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INSULIN RESISTANCE; LEPTIN; LIVER; OBESITY; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 34548362074     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.135590     Document Type: Conference Paper

References (62)

1. Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F et al. (2001). Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci 21, 3639-3645.
2. Anand BK & Brobeck JR (1951). Localization of a 'feeding centre' in the hypothalamus of the rat. Procedings Soc for Exp Biol Med 77, 323-324.
3. Asilmaz E, Cohen P, Miyazaki M, Dobrzyn P, Ueki K, Fayzikhodjaeva G et al. (2004). Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 113, 414-424.
4. Bagdade JD, Bierman EL & Porte D Jr (1967). The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46, 1549-1557.
5. Baskin DG, Breininger JF & Schwartz MW (1999). Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48, 828-833.
6. Baskin DG, Wilcox BJ, Figlewicz DP & Dorsa DM (1988). Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11, 107-111.
7. Bates SH, Kulkarni RN, Seifert M & Myers MG Jr (2005). Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metabolism 1, 169-178.
8. Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y et al. (2003). STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421, 856-859.
9. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC et al. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122-2125.
10. Campfield LA, Smith FJ, Guisez Y, Devos R & Burn P (1995). Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549.
11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-295.
12. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA et al. (2005). The hypothalamic arcuate nucleus: A key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metabolism 1, 63-72.
13. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC et al. (2005). Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199.
14. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V et al. (2006). Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191-203.
15. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C & Flier JS (2000). Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105, 1827-1832.
16. Ernsberger P, Koletsky RJ & Friedman JE (1999). Molecular pathology in the obese spontaneous hypertensive Koletsky rat: A model of syndrome X. Ann N Y Acad Sci 892, 272-288.
17. Gelling RW, Morton GJ, Morrison CD, Niswender KD, Myers MG Jr, Rhodes CJ & Schwartz MW (2006). Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab 3, 67-73.
18. Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M & Shimazu T (1999). Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes 48, 1706-1712.
19. He W, Lam TK, Obici S & Rossetti L (2006). Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci 9, 227-233.
20. Hetherington A & Ranson SW (1940). Hypothalamic lesions and adiposity in the rat. Anat Record 78, 149-172.
21. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C & Flier JS (2004). Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 10, 734-738.
22. Howard JK & Flier JS (2006). Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 17, 365-371.
23. Iguchi A, Burleson PD & Szabo AJ (1981). Decrease in plasma glucose concentration after microinjection of insulin into VMN. Am J Physiol Endocrinol Metab 240, E95-E100.
24. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M et al. (2006). Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 3, 267-275.
25. Kang L, Dunn-Meynell AA, Routh VH, Gaspers LD, Nagata Y, Nishimura T et al. (2006). Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 55, 412-420.
26. Kennedy G (1953). The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 140, 578-592.
27. Kubota N, Terauchi Y, Tobe K, Yano W, Suzuki R, Ueki K et al. (2004). Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 114, 917-927.
28. Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar-Bryan L, Schwartz GJ & Rossetti L (2005). Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11, 320-327.
29. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y & White MF (2004). Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114, 908-916.
30. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD & Kuhajda FP (2000). Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379-2381.
31. + channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 54, 3169-3174.
32. Marks JL & Waite K (1997). Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. J Neuroendocrinol 9, 99-103.
33. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B et al. (2004). AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574.
34. Minokoshi Y, Haque MS & Shimazu T (1999). Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48, 287-291.
35. Morgan K, Obici S & Rossetti L (2004). Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 279, 31139-31148.
36. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H et al. (2004). Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10, 739-743.
37. Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ & Schwartz MW (2005). Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2, 411-420.
38. fak) rats. Endocrinology 144, 2016-2024.
39. Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers MG Jr, Seeley RJ & Schwartz MW (2003). Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: A key mediator of insulin-induced anorexia. Diabetes 52, 227-231.
40. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG Jr & Schwartz MW (2001). Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413, 794-795.
41. Obici S, Feng Z, Karkanias G, Baskin DG & Rossetti L (2002a). Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5, 566-572.
42. Obici S, Feng Z, Morgan K, Stein D, Karkanias G & Rossetti L (2002b). Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271-275.
43. Obici S, Feng Z, Tan J, Liu L, Karkanias G & Rossetti L (2001). Central melanocortin receptors regulate insulin action. J Clin Invest 108, 1079-1085.
44. Obici S, Zhang BB, Karkanias G & Rossetti L (2002c). Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8, 1376-1382.
45. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I & Accili D (2004). Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114, 214-223.
46. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I & Barsh GS (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138.
47. Pardini AW, Nguyen HT, Figlewicz DP, Baskin DG, Williams DL, Kim F & Schwartz MW (2006). Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Res 1112, 169-178.
48. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L & Rossetti L (2005a). Hypothalamic K ATP channels control hepatic glucose production. Nature 434, 1026-1031.
49. Pocai A, Obici S, Schwartz GJ & Rossetti L (2005b). A brain-liver circuit regulates glucose homeostasis. Cell Metabolism 1, 53-61.
50. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G et al. (1996). Specificity of leptin action on elevated blood glucose levels and hypothalmic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531-535.
51. Schwartz MW & Porte D Jr (2005). Diabetes, obesity, and the brain. Science 307, 375-379.
52. Shimomura I, Hammer RE, Ikemoto S, Brown MS & Goldstein JL (1999). Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73-76.
53. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R & Stark KL (1997). Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11, 593-602.
54. Sipols AJ, Baskin DG & Schwartz MW (1995). Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44, 147-151.
55. Song Z & Routh VH (2005). Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 54, 15-22.
56. + channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3, 757-758.
57. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K & Koletsky RJ (1996). Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 14, 130-131.
58. Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B & Kramer MD et al. (2007). Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 5, 383-393.
59. van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM & Pijl H (2004). Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 53, 2529-2534.
60. Woods SC, Lotter EC, McKay LD & Porte D Jr (1979). Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503-505.
61. Xue B & Kahn BB (2006). AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 574, 73-83.
62. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.